Taryn McDonald

Practices

Education and Clerkships

J.D., Southern Methodist University Dedman School of Law, 2013, summa cum laude; Order of the Coif; SMU Law Review Association

B.S., Communication Studies, University of Texas at Austin, 2007, with honors

B.A., Government, University of Texas at Austin, 2007, with honors

Admissions

Texas

Court Admissions

U.S. District Court for the Northern District of Texas, 2013

Profile

Taryn McDonald’s practice focuses on assisting both individuals and corporations facing actual or threatened government enforcement actions. She has represented clients under criminal or civil investigation by various government agencies, including the U.S. Department of Justice, the Office of Inspector General, and the Texas Attorney General’s Office. She also has experience helping clients navigate complex fraud and abuse laws, including the Anti-Kickback Statute and the Stark Law.

Taryn’s practice also includes defending healthcare clients in False Claims Act qui tam litigation and representing providers before Medicare and Medicaid contractors.

Taryn is a member of the Dallas Bar Association and the DFW Chapter of Women in White Collar Defense. Before law school, Taryn worked for both the Texas House of Representatives and the Texas Attorney General’s Office.

Professional Recognition

  • Recognized by Texas Super Lawyers Rising Stars, Thomson Reuters, 2021

  • Included in the "Ones to Watch" category of Best Lawyers in America, Woodward/White, Inc., 2021

  • Recognized in D Magazine's "Best Lawyers in Dallas," D Magazine Partners, 2018

Selected Publications and Speeches

  • “Mitigating False Claims Act Liability Risks for Healthcare Recipients of COVID-19 Funding,” speaker, Strafford CLE webinar, March 24, 2021.
  • “False Claims Act 2020 Year in Review,” speaker, Dallas Bar Association Health Law Section, January 20, 2021.
  • “The Risk of False Claims Act Liability for Recipients of COVID-19 Funding,” co-presenter, Practising Law Institute 1-Hour Program

Year in Review

False Claims Act

The False Claims Act Year in Review 2020

In 2020, the COVID-19 pandemic caused dramatic shifts in the nation’s economic landscape. One thing that did not change was the government’s focus on fraud and violations of the False Claims Act, 31 U.S.C. §§ 3729 et seq. (“FCA”). In fact, that focus only increased with the enactment of several new laws providing trillions of dollars in government funding to affected business and individuals. This Review highlights those and several other key developments from 2020.

Newsletter

Health Law Vitals

Health Law Vitals - A Healthcare Newsletter from Haynes and Boone

The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses the fiduciary duties of directors in medical technology, the promises and pitfalls of telehealth, the FDA's expansion of the Abbreviated 510(k) pathway, and more.

Selected Client Representations

  • Represented a clinical laboratory in False Claims Act qui tam in the Northern District of Texas alleging violations of the Anti-Kickback Statute related to pharmacogenetic testing. See United States ex rels. Choate and Pyburn v. DNA Stat et al. (N.D. Tex.).
  • Represented national hospice provider in False Claims Act qui tam in the Northern District of Texas alleging violations of the Stark Law and Anti-Kickback Statute. See United States ex rel. Capshaw v. White (N.D. Tex.).
  • Represented national healthcare provider in False Claims Act qui tam alleging violations of the Stark Law and Anti-Kickback Statute related to employed physician compensation arrangements and improper coding of evaluation and management procedures.
  • Represented pathology laboratories in False Claims Act qui tam alleging improper billing and violations of the Anti-Kickback Statute.
  • Obtained favorable resolution for healthcare executive in federal and state intervened qui tam False Claims Act case.
  • Obtained favorable resolution for individual under criminal investigation by the Department of Justice.

Email Disclaimer